Yahoo! Finance: BDSI News

BioDelivery Sciences Set to Take Off in 2010 (at Seeking Alpha)

Fri, 18 Dec 2009 22:36:09 Etc/GMT

BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

Fri, 18 Dec 2009 17:47:55 Etc/GMT

BDSI’s dental-pain film does well in phase II trials (at bizjournals.com)

Thu, 17 Dec 2009 16:05:23 Etc/GMT

Hovnanian, BioDelivery: Early Volume Plays (at TheStreet.com)

Thu, 17 Dec 2009 12:19:45 Etc/GMT

BioDelivery Sciences Announces Positive Phase 2 Pain Trial Results for BEMA Buprenorphine (Business Wire)

Thu, 17 Dec 2009 11:00:00 Etc/GMT

RALEIGH, N.C.----BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint was achieved in the Company’s Phase 2 pain study assessing the efficacy and safety of BEMA Buprenorphine.

BioDelivery Sciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference (Business Wire)

Thu, 12 Nov 2009 13:30:00 Etc/GMT

RALEIGH, N.C.----BioDelivery Sciences International, Inc. announced today that Dr. Mark A. Sirgo, President & Chief Executive Officer, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference to be held November 17-18, 2009, at The St.

Chelsea Therapeutics: There Are Safer Rebound Plays (at Seeking Alpha)

Wed, 11 Nov 2009 10:00:35 Etc/GMT

BIODELIVERY SCIENCES INTERNATIONAL INC Financials (EDGAR Online Financials)

Fri, 6 Nov 2009 14:04:25 Etc/GMT

Four Biotech Stocks to Play the Sector Pullback (at Seeking Alpha)

Tue, 3 Nov 2009 14:08:49 Etc/GMT

BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

Tue, 3 Nov 2009 11:03:27 Etc/GMT

Biotech Mailbag: The Reason(s) for This Selloff (at TheStreet.com)

Fri, 30 Oct 2009 11:00:00 Etc/GMT

BioDelivery Sciences Opportunity, Beware Cel Sci Bashers (at Seeking Alpha)

Thu, 29 Oct 2009 08:51:08 Etc/GMT

BioDelivery Sciences International, Inc. - Mark A. Sirgo (Wall Street Transcript)

Tue, 20 Oct 2009 16:28:00 Etc/GMT

"Best In Class" Formulation Of Fentanyl Seen As Breakthrough Treatment By Ladenburg Thalmann Analyst (Wall Street Transcript)

Tue, 20 Oct 2009 12:12:00 Etc/GMT

67 WALL STREET, New York - October 20, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

[video] BioDelivery's Next Milestone (at TheStreet.com)

Fri, 9 Oct 2009 18:43:09 Etc/GMT

BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

Thu, 8 Oct 2009 21:21:03 Etc/GMT

BDSI to begin sales of pain drug for cancer patients (at bizjournals.com)

Thu, 8 Oct 2009 15:05:23 Etc/GMT

BioDelivery Sciences International, Inc. (BDSI) President and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell (GlobeNewswire)

Thu, 8 Oct 2009 14:00:00 Etc/GMT

BioDelivery Sciences and Meda Launch ONSOLIS (fentanyl buccal soluble film) (Business Wire)

Thu, 8 Oct 2009 12:30:00 Etc/GMT

RALEIGH, N.C.----BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS next week for the management of breakthrough pain in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

Tue, 6 Oct 2009 20:21:42 Etc/GMT